Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Treatment of thrombotic antiphospholipid syndrome in adults and children.

Madison JA, Duarte-García A, Zuo Y, Knight JS.

Curr Opin Rheumatol. 2020 May;32(3):215-227. doi: 10.1097/BOR.0000000000000702.

PMID:
32187042
2.

Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.

Cheemalavagu S, McCoy SS, Knight JS.

BMJ Case Rep. 2020 Feb 9;13(2). pii: e232907. doi: 10.1136/bcr-2019-232907.

PMID:
32041760
4.
5.
6.

Pediatric antiphospholipid syndrome.

Madison JA, Zuo Y, Knight JS.

Eur J Rheumatol. 2019 Dec 3:1-10. doi: 10.5152/eurjrheum.2019.19160. [Epub ahead of print] Review.

7.

Disruption of Neutrophil Extracellular Traps (NETs) Links Mechanical Strain to Post-traumatic Inflammation.

Agarwal S, Loder SJ, Cholok D, Li J, Bian G, Yalavarthi S, Li S, Carson WF, Hwang C, Marini S, Pagani C, Edwards N, Delano MJ, Standiford TJ, Knight JS, Kunkel SL, Mishina Y, Ward PA, Levi B.

Front Immunol. 2019 Oct 24;10:2148. doi: 10.3389/fimmu.2019.02148. eCollection 2019.

8.

Extracellular Trap-Mimicking DNA-Histone Mesostructures Synergistically Activate Dendritic Cells.

Weerappuli PD, Louttit C, Kojima T, Brennan L, Yalavarthi S, Xu Y, Ochyl LJ, Maeda ML, Kim HS, Knight JS, Takayama S, Moon JJ.

Adv Healthc Mater. 2019 Nov;8(22):e1900926. doi: 10.1002/adhm.201900926. Epub 2019 Oct 15.

PMID:
31614077
9.

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.

Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H; APS ACTION.

J Thromb Haemost. 2019 Dec;17(12):2069-2080. doi: 10.1111/jth.14596. Epub 2019 Sep 8.

PMID:
31364274
10.

Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by β2 Integrin Mac-1.

Sule G, Kelley WJ, Gockman K, Yalavarthi S, Vreede AP, Banka AL, Bockenstedt PL, Eniola-Adefeso O, Knight JS.

Arthritis Rheumatol. 2020 Jan;72(1):114-124. doi: 10.1002/art.41057.

PMID:
31353826
11.

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.

Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D; APS ACTION.

Semin Arthritis Rheum. 2019 Dec;49(3):464-468. doi: 10.1016/j.semarthrit.2019.04.009. Epub 2019 May 2.

PMID:
31153708
12.

Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome.

Ali RA, Gandhi AA, Meng H, Yalavarthi S, Vreede AP, Estes SK, Palmer OR, Bockenstedt PL, Pinsky DJ, Greve JM, Diaz JA, Kanthi Y, Knight JS.

Nat Commun. 2019 Apr 23;10(1):1916. doi: 10.1038/s41467-019-09801-x.

13.

Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis.

Yadav V, Chi L, Zhao R, Tourdot BE, Yalavarthi S, Jacobs BN, Banka A, Liao H, Koonse S, Anyanwu AC, Visovatti SH, Holinstat MA, Kahlenberg JM, Knight JS, Pinsky DJ, Kanthi Y.

J Clin Invest. 2019 Apr 16;129(7):2872-2877. doi: 10.1172/JCI124804.

14.

Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome.

Vreede AP, Bockenstedt PL, McCune WJ, Knight JS.

Curr Opin Rheumatol. 2019 May;31(3):231-240. doi: 10.1097/BOR.0000000000000595.

15.

Antimicrobial Microwebs of DNA-Histone Inspired from Neutrophil Extracellular Traps.

Song Y, Kadiyala U, Weerappuli P, Valdez JJ, Yalavarthi S, Louttit C, Knight JS, Moon JJ, Weiss DS, VanEpps JS, Takayama S.

Adv Mater. 2019 Apr;31(14):e1807436. doi: 10.1002/adma.201807436. Epub 2019 Jan 30.

16.

To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps.

Boeltz S, Amini P, Anders HJ, Andrade F, Bilyy R, Chatfield S, Cichon I, Clancy DM, Desai J, Dumych T, Dwivedi N, Gordon RA, Hahn J, Hidalgo A, Hoffmann MH, Kaplan MJ, Knight JS, Kolaczkowska E, Kubes P, Leppkes M, Manfredi AA, Martin SJ, Maueröder C, Maugeri N, Mitroulis I, Munoz LE, Nakazawa D, Neeli I, Nizet V, Pieterse E, Radic MZ, Reinwald C, Ritis K, Rovere-Querini P, Santocki M, Schauer C, Schett G, Shlomchik MJ, Simon HU, Skendros P, Stojkov D, Vandenabeele P, Berghe TV, van der Vlag J, Vitkov L, von Köckritz-Blickwede M, Yousefi S, Zarbock A, Herrmann M.

Cell Death Differ. 2019 Mar;26(3):395-408. doi: 10.1038/s41418-018-0261-x. Epub 2019 Jan 8. Review.

18.

Genome-wide DNA methylation analysis in primary antiphospholipid syndrome neutrophils.

Weeding E, Coit P, Yalavarthi S, Kaplan MJ, Knight JS, Sawalha AH.

Clin Immunol. 2018 Nov;196:110-116. doi: 10.1016/j.clim.2018.11.011. Epub 2018 Nov 22.

19.

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.

BJOG. 2019 Apr;126(5):656-661. doi: 10.1111/1471-0528.15469. Epub 2018 Oct 24.

20.

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis.

Liu Y, Carmona-Rivera C, Moore E, Seto NL, Knight JS, Pryor M, Yang ZH, Hemmers S, Remaley AT, Mowen KA, Kaplan MJ.

Front Immunol. 2018 Jul 26;9:1680. doi: 10.3389/fimmu.2018.01680. eCollection 2018.

21.

Bilateral versus unilateral botulinum toxin injections for chronic anal fissure: a randomised trial.

Pilkington SA, Bhome R, Welch RE, Ku F, Warden C, Harris S, Hicks J, Richardson C, Dudding TC, Knight JS, King AT, Mirnezami AH, Beck NE, Nichols PH, Nugent KP.

Tech Coloproctol. 2018 Jul;22(7):545-551. doi: 10.1007/s10151-018-1821-2. Epub 2018 Jul 18.

23.

Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction.

Knight JS, Mazza LF, Yalavarthi S, Sule G, Ali RA, Hodgin JB, Kanthi Y, Pinsky DJ.

Front Immunol. 2018 Jun 11;9:1322. doi: 10.3389/fimmu.2018.01322. eCollection 2018.

24.

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.

Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584.

25.

Histoplasma Tenosynovitis Revealed by Fungal Culture in a Patient Treated with Infliximab.

Woods RJ, Reyes EJ, Knight JS.

J Rheumatol. 2018 Feb;45(2):284-285. doi: 10.3899/jrheum.170505. No abstract available.

26.

Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy.

Jackson WG, Oromendia C, Unlu O, Erkan D, DeSancho MT; Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking.

Blood Adv. 2017 Nov 16;1(25):2320-2324. doi: 10.1182/bloodadvances.2017008185. eCollection 2017 Nov 28.

27.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice.

Wang H, Wang Q, Wang J, Guo C, Kleiman K, Meng H, Knight JS, Eitzman DT.

Sci Rep. 2017 Oct 30;7(1):14360. doi: 10.1038/s41598-017-14307-x.

28.

Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target.

Knight JS, Meng H, Coit P, Yalavarthi S, Sule G, Gandhi AA, Grenn RC, Mazza LF, Ali RA, Renauer P, Wren JD, Bockenstedt PL, Wang H, Eitzman DT, Sawalha AH.

JCI Insight. 2017 Sep 21;2(18). pii: 93897. doi: 10.1172/jci.insight.93897. eCollection 2017 Sep 21.

29.

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.

Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ, Gonzalez E, Knight JS, Uthman I, Willis R, Zhang Z, Wahl D, Zuily S, Tektonidou MG; APS ACTION.

Lupus. 2018 Mar;27(3):399-406. doi: 10.1177/0961203317724219. Epub 2017 Aug 1.

PMID:
28764618
30.

Molecular and biochemical characterisation and recognition by the immune host of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) of the abomasal nematode parasite Teladorsagia circumcincta.

Umair S, Bouchet CLG, Knight JS, Pernthaner A, Simpson HV.

Exp Parasitol. 2017 Oct;181:40-46. doi: 10.1016/j.exppara.2017.07.006. Epub 2017 Jul 27.

PMID:
28757123
31.

Antiphospholipid syndrome: an update for clinicians and scientists.

Vreede AP, Bockenstedt PL, Knight JS.

Curr Opin Rheumatol. 2017 Sep;29(5):458-466. doi: 10.1097/BOR.0000000000000410. Review.

32.

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.

Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, Koch AE, Fox DA, Engelke DR, Kaplan MJ, Markovitz DM.

Nat Commun. 2017 Feb 6;8:14252. doi: 10.1038/ncomms14252.

33.

A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia.

Kazzaz NM, Wilson AM, Kado R, Barnes GD, Knight JS.

Arthritis Care Res (Hoboken). 2017 Aug;69(8):1253-1259. doi: 10.1002/acr.23168. No abstract available.

34.

Molecular and biochemical characterisation and recognition by the immune host of the enolase of the abomasal nematode parasite Teladorsagia circumcincta.

Umair S, Bouchet CL, Knight JS, Pernthaner A, Simpson HV.

Exp Parasitol. 2017 Jan;172:30-38. doi: 10.1016/j.exppara.2016.12.001. Epub 2016 Dec 7.

PMID:
27939767
35.

Intercellular Interactions as Regulators of NETosis.

Kazzaz NM, Sule G, Knight JS.

Front Immunol. 2016 Nov 14;7:453. eCollection 2016. Review.

36.

Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al.

Yalavarthi S, Grenn RC, Knight JS.

Ann Rheum Dis. 2016 Dec;75(12):e82. doi: 10.1136/annrheumdis-2016-210529. Epub 2016 Oct 21. No abstract available.

37.

In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.

Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, Pinsky DJ, Henke PK, Knight JS.

Arthritis Rheumatol. 2017 Mar;69(3):655-667. doi: 10.1002/art.39938.

38.

Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.

Grenn RC, Yalavarthi S, Gandhi AA, Kazzaz NM, Núñez-Álvarez C, Hernández-Ramírez D, Cabral AR, McCune WJ, Bockenstedt PL, Knight JS.

Ann Rheum Dis. 2017 Feb;76(2):450-457. doi: 10.1136/annrheumdis-2016-209442. Epub 2016 Jul 18.

39.

Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus.

Wang H, Knight JS, Hodgin JB, Wang J, Guo C, Kleiman K, Eitzman DT.

Sci Rep. 2016 Jun 30;6:28997. doi: 10.1038/srep28997.

40.

Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies.

Marder W, Knight JS, Kaplan MJ, Somers EC, Zhang X, O'Dell AA, Padmanabhan V, Lieberman RW.

Lupus Sci Med. 2016 Apr 27;3(1):e000134. doi: 10.1136/lupus-2015-000134. eCollection 2016.

41.

Excretory/secretory products of adult Haemonchus contortus and Teladorsagia circumcincta which increase the permeability of Caco-2 cell monolayers are neutralised by antibodies from immune hosts.

Rehman ZU, Deng Q, Umair S, Savoian MS, Knight JS, Pernthaner A, Simpson HV.

Vet Parasitol. 2016 May 15;221:104-10. doi: 10.1016/j.vetpar.2016.03.017. Epub 2016 Mar 21.

PMID:
27084480
42.

Treatment of catastrophic antiphospholipid syndrome.

Kazzaz NM, McCune WJ, Knight JS.

Curr Opin Rheumatol. 2016 May;28(3):218-27. doi: 10.1097/BOR.0000000000000269. Review.

43.

Use of fluorescent lectin binding to distinguish eggs of gastrointestinal nematode parasites of sheep.

Umair S, McMurtry LW, Knight JS, Simpson HV.

Vet Parasitol. 2016 Feb 15;217:76-80. doi: 10.1016/j.vetpar.2015.12.029. Epub 2016 Jan 2.

PMID:
26827865
44.

Reply.

Yalavarthi S, Knight JS.

Arthritis Rheumatol. 2016 May;68(5):1321-2. doi: 10.1002/art.39579. No abstract available.

45.

Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?

Rao AN, Kazzaz NM, Knight JS.

World J Cardiol. 2015 Dec 26;7(12):829-42. doi: 10.4330/wjc.v7.i12.829. Review.

46.

Real-time PCR/DNA melting curve-based assay to identify individual strongylid larvae recovered from ovine faecal cultures.

Knight JS, Bisset SA.

Vet Parasitol. 2015 Dec 15;214(3-4):337-41. doi: 10.1016/j.vetpar.2015.10.019. Epub 2015 Oct 24.

PMID:
26526096
47.

Immunomodulatory effects of adult Haemonchus contortus excretory/secretory products on human monocyte-derived dendritic cells.

Rehman ZU, Knight JS, Koolaard J, Simpson HV, Pernthaner A.

Parasite Immunol. 2015 Dec;37(12):657-69. doi: 10.1111/pim.12288.

48.

Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival.

Kazzaz NM, Coit P, Lewis EE, McCune WJ, Sawalha AH, Knight JS.

Lupus Sci Med. 2015 Sep 23;2(1):e000117. doi: 10.1136/lupus-2015-000117. eCollection 2015.

49.

Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.

Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, Hernández-Ramírez D, Bockenstedt PL, Liaw PC, Cabral AR, Knight JS.

Arthritis Rheumatol. 2015 Nov;67(11):2990-3003. doi: 10.1002/art.39247.

50.

Molecular and biochemical characterisation of abomasal nematode parasites Teladorsagia circumcincta and Haemonchus contortus phosphofructokinases and their recognition by the immune host.

Umair S, Dagnicourt E, Knight JS, Simpson HV, Pernthaner A.

Exp Parasitol. 2015 Apr-May;151-152:64-72. doi: 10.1016/j.exppara.2015.01.020. Epub 2015 Feb 3.

PMID:
25662436

Supplemental Content

Loading ...
Support Center